Trial intelligence / Profile preview

Aromatherapy vs Aricept vs placebo in agitation in Alzheimer's disease

2005-003269-17Phase 4Completed

Sponsor
Manchester Mental Health and Social Care NHS Trust
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of donepezil in Alzheimer's disease (AD) (3 arms), sponsored by Manchester Mental Health and Social Care NHS Trust. Primary endpoint: Change in measures of agitation. Started Mar 2006; status: completed.

02

Drugs

donepezil
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on 2005-003269-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003269-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call